INS and obesity disorder: Rodent model studies of estrogen deficiencies as well as clinical studies in women with polycystic ovarian syndrome, postmenopausal women, and aromatase-deficient men (42, 43) demonstrate protective effects of estrogen on metabolic function by reducing proinflammatory cytokines and maintaining insulin sensitivity during obesity (12, 20, 44, 45).